Axsome Therapeutics (AXSM): Short-Term Debt to Equity Ratio
Axsome Therapeutics (AXSM) focuses on developing innovative therapies for CNS disorders, accelerating the launch of medications for migraine and depression. Business scaling is supported by outsourcing production to third-party contractors to optimize inventory. Distribution efficiency through diversified channels ensures high margins, with the current figure standing at 1.05. The price indicator on the chart below visualizes the dynamics of the company's debt load and capital.
Metric breakdowns and analytics for axsome.com (AXSM)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
General company analysis:Axsome Therapeutics Inc, AXSM
For Axsome Therapeutics (AXSM), which scales CNS drug sales via contract manufacturing, the history of the short-term debt-to-equity ratio reflects the efficiency of working capital management without capital expenditures on plants. The current liabilities-to-equity ratio measures liquidity risk: an increase in this metric signals a balance sheet overburdened by debt, which could lead to share dilution and a decline in the asset's investment attractiveness.
Competing companies
Biogen Corp - Short-Term Debt to Capital|Current Liabilities to Capital Neurocrine Corp NBIX|Short-Term Debt to Equity Ratio RGC (Regencell Bioscience)|acadia-pharm.com - Short-Term Debt to Capital|Short-Term Debt to Equity Xenon (XENE)|VKTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity SUPN|Catalyst Corp (CPRX) - Current Liabilities to Capital|DNLI (Denali Therapeutics) - Short-Term Debt to Capital|Short-Term Debt to Capital harmonybiosciences.com (HRMY)|Short-Term Debt to Equity Ratio Biohaven BHVN|Short-Term Debt to Capital Ratio AMLX (Amylyx Pharmaceuticals Inc)|Short-Term Debt to Equity TRVI|Praxis Corp - Short-Term Debt to Capital Coefficient|AVXL (Anavex Life Sciences) - Short-Term Debt to Equity|CBLL: Current Liabilities to Capital|PRTA (Prothena Corp) - Short-Term Debt to Equity|Alector (ALEC) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital ANNX (Annexon Inc.)|Current Liabilities to Capital Omeros Corp. (OMER)|Neurogene Inc. (NGNE) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital acimmune.com ACIU|Short-Term Debt to Equity Ratio Voyager Therapeutics, Inc. (VYGR)|Short-Term Loans to Capital Ratio Neumora NMRA|Short-Term Debt to Capital Scilex Holding Co. (SCLX)|TVGN - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ACOG|CGTX (cogrx.com) - Current Liabilities to Capital|IKT - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Cassava Sciences Inc|Short-Term Debt to Capital ASRT|Short-Term Debt to Capital COYA (coyatherapeutics.com)|Vistagen (VTGN) - Short-Term Debt to Equity|Current Liabilities to Equity Ovid Therapeutics Inc OVID|ABOS (Acumen Pharmaceuticals, Inc.) - Short-Term Debt to Capital|CervoMed, Inc. (CRVO) - Current Liabilities to Capital|ATHE: Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Clene|PepGen Inc (PEPG) - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio jupiterneurosciences.com|RLMD (Relmada Therapeutics, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Annovis Bio Inc (ANVS)|Grace Therapeutics - Short-Term Debt to Capital|Firefly Neuro - Short-Term Debt to Equity Ratio|Short-Term Debt to Equity KLTO (ANEW Medical, Inc.)|NRSN - Short-Term Debt to Capital Coefficient|RVPH: Short-Term Debt to Capital|Short-Term Debt to Capital MetaVia|Short-Term Debt to Equity Ratio NeurAxis, Inc (NRXS)|Short-Term Debt to Capital Ratio HSDT|PASG (Passage Bio, Inc.) - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient NEUP (bionomics.com.au)|Minerva Neurosciences, Inc. - Short-Term Debt to Equity|Athira Pharma Inc - Short-Term Debt to Equity Ratio|Addex Therapeutics, Ltd. (ADXN) - Short-Term Debt to Equity|ALZN - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital CYCN|Current Liabilities to Capital Protagenic Therapeutics, Inc.|KTTA (Pasithea Therapeutics Corp) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital CRGT|Avenue Therapeutics, Inc (ATXI) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital BCLI (BrainStorm Cell Therapeutics Inc.)|CARA: Short-Term Debt to Equity|Current Liabilities to Capital chromocell.com CHRO|Eliem - Short-Term Debt to Capital|Intra-Cellular Therapies (ITCI) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Longboard Pharma|MRNS (Marinus Pharma) - Short-Term Debt to Capital Ratio|NKGN: Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient NRBO|Sage Therapeutics - Short-Term Debt to Equity|Current Liabilities to Capital SNPX (Synaptogenix Inc.)|Trevena, Inc - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Vigil Neuroscience Inc. VIGL|WENA (Anew Medical, Inc.) - Short-Term Debt to Capital|cerevel.com (CERE) - Current Liabilities to Capital